Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

Covishield vaccine

SII Stopped Covishield Production In December 2021, No Takers For Booster Shots As People Are Fed Up: Poonawalla

1yr News Headlines

Serum Institute of India CEO Adar Poonawalla (Pic Via Twitter)

As India Crosses 100 Crore Covid-19 Vaccinations, Here Are Four Things We Need To Realise

Arihant Pawariya

PM Modi receives his vaccination against Covid-19. (Pic Via Twitter)

The First Quarter Billion Doses: Looking Back And Ahead

Covid-19 vaccine doses (Representative image)

Bharat Biotech Calls Out ‘Covishield vs Covaxin’ Comparative Study, Adds That Report Had Lot Of Flaws

Covid-19 vaccine. (Representative image)

CoWIN App Reconfigured To Permit Online Bookings For 2nd Covishield Dose Only After 84 days

CoWIN app

WHO Says B.1.617 Is Now ‘Variant of Concern’: What Do We Know So Far About Double Mutant Covid Variant

Bhaswati Guha Majumder

Coronavirus (Representative Image)

First Dose Of Oxford-Astrazeneca Covid-19 Vaccine Reduces Risk Of Death By 80 Per Cent: UK Study

SII's Covishield vaccine (Pic Via Twitter)

Petition Filed In Bombay HC Seeking Z+ Security For SII CEO Adar Poonawalla, His Family

Adar Poonawalla (Image Credits: Twitter)

Govt Rubbishes Reports Claiming No New Vaccines Orders After March, Says Another 16 Crore Doses Ordered In April

Covid-19 vaccine - representative image (Twitter)

As Covid-19 Cases Rise, Serum Institute Plans To Begin Overseas Production Of Covishield Vaccine: Report

SII's Covishield vaccine (Pic Via Twitter)

US Dispatches Five Tonnes Of Oxygen Concentrators To India; More Consignments To Be Delivered Soon

Representative Image

Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra

Covid-19 vaccine. (Representative image)

Seven More Covid-19 Vaccine Candidates In Clinical Trials: Dr Harsh Vardhan

Union Minister for Health Dr Harsh Vardhan (Pic Via Twitter)

AstraZeneca COVID-19 Vaccine Side Effects: India To Conduct Deeper Review After Suspension Of Use By Some Nations

AstraZeneca

After Trudeau’s Request, India In Principle Approves Supply Of Half-A-Million Covishield Vaccines To Canada

Prime Minister Justin Trudeau meets Prime Minister Narendra Modi.

Pakistan To Receive ‘Made In India’ Covid19 Vaccines As Part Of Covax Global Alliance

Covishield vaccine (Pic Via Twitter)

PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: Report

PM Narendra Modi

Serum Institute CEO Adar Poonawalla Takes Covid Vaccine To 'Endorse' Its Safety And Efficacy

Covid-19 vaccine - representative image (Twitter)

Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To Government

Bharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)

Get Swarajya in your inbox.